Evaluating the utility of procedural diagnostics in deciding when and where to place a stent, as well as the safety and efficacy of Passeo-18 Lux DCB associated to Pulsar-18 BMS placement
Indicated for balloon dilatation of the stenotic portion of a lower limb artery for the purpose of improving perfusion.*
Indicated to dilate stenosis in the renal, iliac1, femoral, popliteal and infrapopliteal arteries and for the treatment of obstructive lesions of native or synthetic arteriovenous dialysis fistulae.*
BIOTRONIK announced the two-year-results from the BIOLUX P-III BENELUX all-comers registry, presented by Principal Investigator Prof. Frank Vermassen at CIRSE 2023 in Copenhagen, Denmark.1 The prospective, international, multicenter post-market registry evaluated the safety and efficacy of the Passeo®-18 Lux® drug-coated balloon (DCB) catheter in isolated popliteal artery lesions. This indication is considered a difficult vessel bed to treat due to its biomechanical constraints that usually preclude the placement of stents. BIOLUX P-III BENELUX registry enrolled 99 patients in Belgium, the Netherlands, and Luxembourg with Rutherford 2-5 disease and at least two centimeters of healthy vessel segment between lesions in the popliteal artery and lesions in the distal superficial femoral artery. All patients were treated with the Passeo-18 Lux DCB. The bail-out stenting rate was 14%. At 24 months: “We face a scarcity of data evaluating endovascular therapy for isolated popliteal artery lesions, known
Drug-Releasing Pantera Lux PTCA Balloon Catheter Registry
Our broad range of products work to restore blood flow to vessels of the heart (coronary) and body (peripheral) that are narrowed or blocked. We produce a full range of stent systems, balloon catheters and guide wires for patients with coronary and peripheral artery disease.BIOTRONIK is a true innovator in the field, having introduced Pulsar, the world's first 4 F-compatible stent for treating long lesions, in 2009 and Orsiro, the industry's first hybrid drug-eluting stent, in 2011. Over the years our wide range of vascular intervention innovations include Orsiro DES, Resorbable Magnesium Scaffold, Drug Coated Balloon Catheters, Multifunctional Catheters and many more. Patient well being is our top priority and has been for 60 years.
Coronary drug-eluting stent (DES) systems are stents which are pre-mounted on a balloon catheter. DES are used for the treatment of coronary arteries and release an anti-proliferative drug to the vessel wall.
Our technologies enable physicians to provide highly effective therapies to patients suffering from cardiovascular and endovascular diseases. In the field of electrophysiology, BIOTRONIK offers state-of-the-art solutions that diagnose and treat patients with cardiac arrhythmias.
